JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
Peoples Bancorp of North Carolina
PEBK
$230M
| $370K | ﹤0.01% |
15,627
+2,002
| +15% | +$47.7K |
2017 Q4
13 quarters
|
|
|
ICBK
4702
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $370K | ﹤0.01% |
15,434
+391
| +3% | +$8.95K |
2020 Q2
3 quarters
|
|
|
MBII
4703
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $369K | ﹤0.01% |
176,943
+1,669
| +1% | +$3.47K |
2018 Q2
11 quarters
|
|
4704
Ohio Valley Banc Corp
OVBC
$209M
| $365K | ﹤0.01% |
15,041
+2,015
| +15% | +$49.9K |
2017 Q4
13 quarters
|
|
|
FNHC
4705
DELISTED
FedNat Holding Company Common Stock
FNHC
| $365K | ﹤0.01% |
78,742
-46,924
| -37% | -$277K |
2016 Q4
17 quarters
|
|
|
PINE
4706
Alpine Income Property Trust
PINE
$311M
| $364K | ﹤0.01% |
20,950
+630
| +3% | +$10.7K |
2020 Q2
3 quarters
|
|
|
SAL
4707
DELISTED
Salisbury Bancorp, Inc.
SAL
| $363K | ﹤0.01% |
16,338
+666
| +4% | +$13.7K |
2020 Q2
3 quarters
|
|
4708
PUT
Crown Castle
CCI
$28.1B
| $361K | ﹤0.01% |
+2,100
| New | +$336K |
2021 Q1
0 quarters
|
|
4709
PUT
Barnes & Noble Education
BNED
$405M
| $360K | ﹤0.01% |
+442
| New | +$304K |
2021 Q1
0 quarters
|
|
4710
First Trust Water ETF
FIW
$1.72B
| $360K | ﹤0.01% |
4,600
| – | – |
2017 Q3
14 quarters
|
|
4711
Pluri
PLUR
$12.7M
| $360K | ﹤0.01% |
9,430
+8,601
| +1,038% | +$451K |
2020 Q4
1 quarter
|
|
|
DSKE
4712
DELISTED
Daseke, Inc. Common Stock
DSKE
| $360K | ﹤0.01% |
42,357
+22,083
| +109% | +$135K |
2017 Q3
14 quarters
|
|
|
ORGS
4713
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $358K | ﹤0.01% |
6,257
+345
| +6% | +$22.5K |
2020 Q2
3 quarters
|
|
4714
Telefônica Brasil
VIV
$18.2B
| $355K | ﹤0.01% |
+45,123
| New | +$377K |
2021 Q1
0 quarters
|
|
|
LJPC
4715
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $355K | ﹤0.01% |
83,632
+17,610
| +27% | +$97K |
2017 Q4
13 quarters
|
|
|
BTAI
4716
DELISTED
BioXcel Therapeutics
BTAI
| $354K | ﹤0.01% |
513
+150
| +41% | +$121K |
2019 Q2
7 quarters
|
|
|
DOO
4717
Bombardier Recreational Products
DOO
$3.89B
| $354K | ﹤0.01% |
4,065
+1,895
| +87% | +$139K |
2020 Q3
2 quarters
|
|
|
HUIZ
4718
Huize Holding Ltd
HUIZ
$13.7M
| $354K | ﹤0.01% |
+8,464
| New | +$349K |
2021 Q1
0 quarters
|
|
4719
Immatics
IMTX
$1.28B
| $354K | ﹤0.01% |
+31,580
| New | +$358K |
2021 Q1
0 quarters
|
|
4720
Invesco S&P 500 GARP ETF
SPGP
$2.09B
| $354K | ﹤0.01% |
+4,344
| New | +$338K |
2021 Q1
0 quarters
|
|
|
PAMT
4721
PAMT Corp
PAMT
$249M
| $354K | ﹤0.01% |
22,924
+552
| +2% | +$7.94K |
2016 Q4
17 quarters
|
|
4722
Avalo Therapeutics
AVTX
$802M
| $352K | ﹤0.01% |
40
+6
| +18% | +$56.7K |
2019 Q1
8 quarters
|
|
4723
Tarsus Pharmaceuticals
TARS
$3.53B
| $352K | ﹤0.01% |
10,912
-5,871
| -35% | -$217K |
2020 Q4
1 quarter
|
|
4724
iShares US Pharmaceuticals ETF
IHE
$1.61B
| $351K | ﹤0.01% |
5,919
-1,029
| -15% | -$62.1K |
2014 Q1
28 quarters
|
|
|
UBFO
4725
DELISTED
United Security Bancshares
UBFO
| $351K | ﹤0.01% |
42,978
-1,688
| -4% | -$12.8K |
2017 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.